Switzerland
Novostia, headquartered in Switzerland, is a promising medical device startup founded in 2017. The company specializes in developing innovative artificial heart valves suitable for patients of any age, including children. With its slogan, "Heart valves for life, for patients of any age, including children," Novostia focuses on transforming treatment for aortic and mitral valve disease.
As the health care industry continues to seek novel solutions for complex cardiovascular issues, Novostia's commitment to advancing their technology to clinical trials and regulatory approvals positions them as a key player in this space. The potential to improve the quality of life for millions of patients worldwide offers a compelling value proposition for investors.
In its latest funding round on 01 May 2023, the company secured a €2.50M Series A investment. This financial backing underscores confidence in Novostia's innovative approach and their trajectory in the Health Care and Medical Devices industries.
